文献速递临床试验与 GCP基础与转化研究

动物双歧杆菌乳亚种B94对普拉德-威利综合征成人胃肠道健康的影响:随机对照试验研究方案

The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-04-27

本研究为一项20周随机双盲安慰剂对照交叉试验,计划招募36名18-75岁普拉德-威利综合征成人,评估每日摄入动物双歧杆菌乳亚种B94对排便频率、粪便性状及胃肠道症状的影响,并探索性分析粪便微生物群。

要点

  • 普拉德-威利综合征成人常便秘,本研究为首个评估B94的随机对照试验。
  • 采用交叉设计,每阶段4周干预,前后设4周基线或洗脱期。
  • 主要观察指标为排便频率和粪便性状(转运时间替代指标)。

核心结论

  • 本研究旨在确定每日摄入B94对普拉德-威利综合征成人排便频率、粪便性状和胃肠道症状的效果。

研究设计与样本

  • 20周随机双盲安慰剂对照交叉试验,计划招募36名18-75岁普拉德-威利综合征成人。
  • 受试者随机接受B94或安慰剂各4周,前后设4周基线和4周洗脱期。

关键数值与推荐

  • 每日记录排便频率和粪便性状(转运时间替代指标),并收集膳食摄入数据。
  • 每阶段收集一次粪便用于探索性微生物群分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Constipation is a frequent problem in adults with Prader-Willi syndrome. Certain probiotics have been shown to improve transit and gastrointestinal symptoms of adults with functional constipation. The aim of this study is to determine the effect of daily consumption of Bifidobacterium animalis ssp. lactis B94 (B. lactis B94) on stool frequency, stool form, and gastrointestinal symptoms in adults with Prader-Willi syndrome. METHODS: Adults with Prader-Willi syndrome (18-75 years old, n = 36) will be recruited and enrolled in a 20-week, randomized, double-blind, placebo-controlled, crossover study. Study subjects will be randomized to B. lactis B94 or placebo each for a 4-week period, preceded by a 4-week baseline and followed by 4-week washouts. Subjects will complete daily records of stool frequency and stool form (a proxy of transit time). Dietary intake data also will be collected. Stools, one in each period, will be collected for exploratory microbiota analyses. DISCUSSION: To our knowledge, this is the first randomized controlled trial evaluating the effectiveness of B. lactis in adults with Prader-Willi syndrome. The results of this study will provide evidence of efficacy for future clinical trials in patient populations with constipation. TRIAL REGISTRATION: ClinicalTrials.gov ( NCT03277157 ). Registered on 08 September 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Alyousif Z, Miller JL, Sandoval MY, et al. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29703235. doi:10.1186/s13063-018-2648-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。